Physician profile
Bradley Hoopingarner
NPI 1063401594
$478.80
in general payments reported to CMS, 2019-2025
12 companies · $176 in 2025
The $176 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.88 · 2022: $89.61 · 2023: $102 · 2024: $82.23 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $360.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $144.12 | 2022-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Ironshore Pharmaceuticals INC. | $77.46 | 2021-2024 | Jornay Pm |
| Glaxosmithkline, LLC. | $52.24 | 2021-2025 | Bexsero, Penmenvy |
| Sobi, INC | $34.94 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $29.27 | 2025 | Zoryve |
| Acadia Pharmaceuticals INC | $28.97 | 2025 | Daybue |
| Collegium Pharmaceutical, INC. | $22.71 | 2025 | Jornay Pm |
| Organon LLC | $22.56 | 2023 | Nexplanon |
| Cranial Technologies, INC | $20.21 | 2025 | Doc Band |
| Verrica Pharmaceuticals INC. | $16.77 | 2024 | Ycanth |
| Seqirus USA INC | $15.21 | 2025 | Flucelvax |
| Supernus Pharmaceuticals, INC. | $14.34 | 2023 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Hoopingarner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.